mHealth Technologies for Heart Failure
(iCardia4HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two mobile health technologies to help individuals with chronic heart failure manage their condition more effectively. One treatment, MyApps, uses health apps and devices to track and manage heart health. The other, Text4HF, sends personalized text messages to encourage better self-care habits. Researchers aim to determine if these tools, alone or combined, can reduce hospitalizations and improve daily management of heart failure. Individuals with Stage C heart failure, currently managing their condition with medication and having had recent heart-related hospital stays, might be suitable for this trial. As a Phase 2/3 trial, this research measures the treatment's effectiveness in an initial, smaller group and represents the final step before FDA approval, offering participants a chance to contribute to advancing heart failure care.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications. However, it mentions that participants must be actively treated with oral loop diuretics for chronic heart failure, so you may need to continue those.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both the MyApps and Text4HF programs are generally safe for people with heart failure. Studies have found that using mobile health apps and devices, like MyApps, is usually easy for people to manage. These tools help track and manage heart health without major issues. Research on similar apps has shown they can reduce risks without causing significant side effects.
The Text4HF program, which sends personalized text messages to encourage better self-care, has also been tested in other studies. These studies found it to be a safe way to support heart health by helping people adhere to their self-care routines, with no major safety concerns.
Using MyApps and Text4HF together is also considered safe. Early findings suggest this combined approach works well and is user-friendly. Overall, these programs appear to be safe options for managing heart failure.12345Why are researchers excited about this trial's treatments?
Researchers are excited about exploring mHealth technologies like MyApps and Text4HF for heart failure management because these tools offer a fresh approach to self-care. Unlike traditional treatments that mainly focus on medication and regular clinical visits, MyApps uses a combination of health apps and connected devices to help patients monitor and manage their condition daily. Text4HF takes it a step further by providing personalized text messages to boost patients' knowledge and confidence in managing heart failure. Both treatments aim to empower patients with real-time data and support, potentially improving self-management and outcomes in a way that standard care alone might not achieve.
What evidence suggests that this trial's treatments could be effective for heart failure?
Research has shown that mobile health apps like MyApps, which participants in this trial may receive, help people with heart failure take better care of themselves. These apps improve self-care, enabling people to manage their health better and potentially reduce hospital visits. Studies indicate that using these apps and devices can decrease time spent in the hospital and lower the risk of heart-related issues.
Similarly, personalized text messages from programs like Text4HF, another treatment option in this trial, assist heart failure patients by reminding them to follow their care routines. This method encourages healthy habits and helps people maintain consistency in their self-care.
When MyApps and Text4HF are used together, as in one of the trial arms, early research suggests they may be even more effective in enhancing self-care and reducing hospital stays. This combination leverages both technology and personalized messages to promote better health habits.23467Who Is on the Research Team?
Spyros Kitsiou, PhD
Principal Investigator
University of Illinois Chicago
Are You a Good Fit for This Trial?
This trial is for people with chronic heart failure. Participants should be willing to use mobile health apps and devices daily for self-care, and receive tailored text messages aimed at improving their adherence to self-care routines.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Induction
Participants receive the MyApps and/or Text4HF interventions to promote heart failure self-care adherence
Adoption
Continued use of MyApps and/or Text4HF interventions with reduced frequency of text messages
Follow-up
Participants are monitored for maintenance efficacy of interventions and health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- MyApps
- Text4HF
Trial Overview
The study tests two interventions: 'MyApps', which involves using mHealth apps and devices for daily heart failure care, and 'Text4HF', a series of personalized text messages. It will assess if these can improve self-care and reduce hospitalization or death from cardiovascular causes.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Participants allocated to the Text4HF group will receive the same components and devices as the usual care group (usual care, patient education, and connected health devices), plus individually tailored Text Messages targeting health beliefs, HF-knowledge, and self-efficacy about HF self-care. Participants will receive 4-6 TMs/week during the induction phase (0 to 3 months), and 2-4 TMs per week during the adoption period (3 to 6 months).Tailoring of the TMs is guided by participants' responses to validated instruments assessing intervention target variables at baseline and 3 months
Participants in this group will receive the MyApps and Text4HF intervention components, combined.
In addition to usual care and patient education resources, participants in the MyApps group will receive three commercially available apps (Heart Failure Storylines, Withings Health Mate, and Fitbit), and three connected health devices (Withings Body Cardio Scale, Withings BP monitor, and Fitbit activity tracker). The apps interface with the devices via Bluetooth offering patients a comprehensive set of mHealth tools that support the core elements of HF self-care (maintenance, self-monitoring, and self-management).
Participants assigned to the usual care group will receive (1) standard care, (2) patient education about HF self-care, and (3) three connected health devices. Usual care includes follow-up appointments every 2-3 months with a multidisciplinary team at the outpatient HF clinic. Patient education includes resources about HF self-care from the American Heart Association and Heart Failure Society of America. Connected health devices include the Withings Weight Scale, Withings blood pressure monitor, and Fitbit Charge 6 activity tracker (wrist-based with heart rate sensor). Participants will receive the devices at baseline along with training by research staff on how to use the devices to perform daily self-monitoring of weight, blood pressure, and physical activity/inactivity. The Withings devices have a cellular antenna for automatic transmission of data to our study server (iCardia). Fitbit will be paired with the participant's smartphone.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Published Research Related to This Trial
Citations
Patient-Centered mHealth Intervention to Improve Self-Care in ...
The primary efficacy outcome was change in HF self-care subscale scores (maintenance, symptom perception, and self-care management) at 8 weeks, ...
iCardia4HF: Multi-component mHealth Intervention for ...
The main questions this study aims to answer are: Can the use of consumer mHealth apps and devices (MyApps) improve heart failure self-care and reduce days lost ...
Evaluation of Heart Failure Apps to Promote Self-Care
We conducted a systematic search of all apps available exclusively for HF self-care across Google Play and the App Store.
mHealth Technologies for Heart Failure (iCardia4HF Trial)
Research suggests that mobile health apps can help people with heart failure manage their condition better by reducing hospital visits and improving their ...
Patient-Centered mHealth Intervention to Improve Self ...
MyApps consisted of 3 popular consumer-grade mHealth apps (Heart Failure ... heart failure based on the data I collect from the mobile app and smart devices ...
Patients' Experiences Using a Mobile Health App for Self ...
Publicly available patient-focused mobile health (mHealth) apps are being increasingly integrated into routine heart failure (HF)–related ...
Effectiveness of mobile health applications on clinical ...
Mobile health apps have the potential to lower the incidence of major adverse cardiac events (MACEs), readmission rates, and blood lipids in patients with CHD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.